COSCIENS Biopharma (ET80) Q3 2023 Earnings Report
DE:ET80 Q3 2023 EPS Results
- Actual EPS
- -EUR 3.03
- Consensus EPS
- -EUR 2.18
- Beat/Miss
- Missed by -EUR 0.86
- One Year Ago EPS
- -EUR 2.50
DE:ET80 Q3 2023 Revenue Results
- Actual Revenue
- EUR 2,569.564
- Expected Revenue
- EUR 2.04M
- Beat/Miss
- Missed by -EUR 2.03M
- YoY Revenue Growth
- -99.83%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/09/2023
- Time
- Before Open
- Conference Call
- Thursday, November 9, 2023
DE:ET80 Upcoming Earnings
COSCIENS Biopharma's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q3 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ET80 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―- | -1.51 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | ―-0.17 | -2.26 | 92.44% (+2.09) | |
| May 12, 2026 | 2026 (Q1) | ―-0.45 | -3.19 | 85.97% (+2.75) | |
| Apr 15, 2026 | 2025 (Q4) | ―-1.83 | -5.75 | 68.15% (+3.92) | |
| Nov 11, 2025 | 2025 (Q3) | ―-1.51 | -3.54 | 57.39% (+2.03) | |
| Aug 14, 2025 | 2025 (Q2) | ―-2.26 | -1.23 | -84.06% (-1.03) | |
| May 13, 2025 | 2025 (Q1) | ―-1.04 | -12.69 | 91.84% (+11.65) | |
| Apr 09, 2025 | 2024 (Q4) | ―-3.19 | -9.08 | 64.82% (+5.89) | |
| Nov 12, 2024 | 2024 (Q3) | ―-4.95 | -9.1 | 45.59% (+4.15) | |
| Aug 08, 2024 | 2024 (Q2) | ―- | -0.33 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed